| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |